Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug 1;13(2):149-59.
doi: 10.1016/j.stem.2013.07.001.

Genetic and epigenetic variations in iPSCs: potential causes and implications for application

Affiliations
Review

Genetic and epigenetic variations in iPSCs: potential causes and implications for application

Gaoyang Liang et al. Cell Stem Cell. .

Abstract

The ability to reprogram somatic cells to induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine. However, recent studies on the genetic and epigenetic variations in iPSCs have raised concerns that these variations may compromise the utility of iPSCs. In this Perspective, we review the current understanding of genetic and epigenetic variations in iPSCs, trace their causes, discuss the implications of these variations for iPSC applications, and propose approaches to cope with these variations.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Sources of genetic variations in iPSC lines
Genetic variations of iPSC lines may have different sources. (A) Individual starting somatic cells (diamond) within a culture (rounded rectangle) bear subtle genetic variations (colored crosses), which can be captured and manifested in the iPSC (circle) lines for the clonal nature of the transcription factor (TF)-mediated iPSC derivation process. (I) Given that reprogramming occurs stochastically among the starting cell population, the genetic variations captured in iPSC lines may have random patterns. (II) If reprogramming preferentially takes place in cells bearing genetic variations conferring selective advantage (green crosses), the iPSC-manifested variations may show functional enrichment. (B) The reprogramming process per se may introduce variations. The cells that undergo reprogramming may have enhanced genomic instability (striped circles), resulting in de novo mutations in iPSCs. Early-passage iPSCs may display mosaicism of de novo mutations, which are subjected to selection along passaging. Mutations conferring advantage in self-renewal or proliferation (green crosses) eventually prevails the culture; those deleterious for cell survival (red crosses) are selected against in culture; while other neutral mutations (crosses with other colors) undergo genetic drift. (C) Mutations that arise during prolonged culturing are subjected to similar selection described in B.
Figure 2
Figure 2. Genetic and epigenetic variations, their causes, functional consequences and impacts on application
iPSCs derived from transcription factor (TF)-mediated reprogramming may bear different types of genetic (blue boxes) or epigenetic variations (purple boxes) that can be introduced from varied sources (grey boxes) during the derivation and manipulationsof iPSCs. These variations may lead to different functional consequences (red boxes) that need to be considered when iPSCs or their derivatives are used for applications (green boxes). Solid lines, reported or definite connections; dotted lines, potential connections.

References

    1. Abyzov A, Mariani J, Palejev D, Zhang Y, Haney MS, Tomasini L, Ferrandino AF, Rosenberg Belmaker LA, Szekely A, Wilson M, et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature. 2012;492:438–442. - PMC - PubMed
    1. Aladjem MI, Spike BT, Rodewald LW, Hope TJ, Klemm M, Jaenisch R, Wahl GM. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Current biology: CB. 1998;8:145–155. - PubMed
    1. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature biotechnology. 2011;29:1132–1144. - PMC - PubMed
    1. Anguera MC, Sadreyev R, Zhang Z, Szanto A, Payer B, Sheridan SD, Kwok S, Haggarty SJ, Sur M, Alvarez J, et al. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell stem cell. 2012;11:75–90. - PMC - PubMed
    1. Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, Sugiura M, Ideno H, Shimada A, Nifuji A, et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature. 2013;494:100–104. - PubMed

Publication types